Bottom line
IBCA vs IGIB: the short answer
IBCA (iShares iBonds Dec 2035 Term Corporate ETF) and IGIB (iShares 5-10 Year Investment Grade Corporate Bond ETF) are both etfs.
But IGIB is far broader, holding 2,990 positions to 416 for IBCA, so beyond the top names it adds exposure IBCA doesn't have.
IGIB is cheaper at 0.04% vs 0.1% — a difference of $6.00 a year per $10,000 invested.
Updated Nov 19, 2026
IBCA vs IGIB side by side
| IBCA | IGIB | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | iShares |
| Category | Corporate Bond | Corporate Bond |
| Expense ratio | 0.1% | 0.04% |
| Annual cost per $10k | $10 | $4 |
| 10-yr cost on $10k (prospectus) | — | $51 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | — | +9.6% |
| 5-yr return (annualized) | — | +1.0% |
| 10-yr return (annualized) | — | +3.4% |
| Best quarter | — | +10.3% |
| Worst quarter | — | −7.0% |
| Net assets (fund) | $375.7M | $18.2B |
| Number of holdings | 416 | 2,990 |
| Portfolio turnover | 1% | 27% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
2 of IBCA's top 25 holdings also appear in IGIB's top 25.
| Holding | IBCA | IGIB |
|---|---|---|
| BlackRock Funds III | 16.59% | 11.07% |
| Meta Platforms, Inc. | 1.81% | 0.23% |
Source: SEC Form N-PORT
IBCA top 10
- BlackRock Funds III — 16.59%
- Meta Platforms, Inc. — 1.81%
- Oracle Corp. — 1.09%
- Alphabet, Inc. — 0.94%
- Amazon.com, Inc. — 0.91%
- Broadcom, Inc. — 0.76%
- Broadcom, Inc. — 0.72%
- AbbVie, Inc. — 0.69%
- Synopsys, Inc. — 0.68%
- AT&T, Inc. — 0.68%
IGIB top 10
- BlackRock Funds III — 11.07%
- Meta Platforms Inc — 0.23%
- Amazon.com Inc — 0.22%
- Anheuser-busch Co/inbev — 0.20%
- Bank Of America Corp — 0.19%
- Bank Of America Corp — 0.19%
- Bank Of America Corp — 0.19%
- Mars Inc — 0.19%
- Pfizer Investment Enter — 0.18%
- Jpmorgan Chase & Co — 0.18%
FAQ
What is the difference between IBCA and IGIB?
Which is cheaper, IBCA or IGIB?
Should I own both IBCA and IGIB?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.